{
  "model_name": "google/gemini-2.5-flash",
  "model_id": "google/gemini-2.5-flash",
  "content": "```json\n{\n    \"primary_diagnosis\": {\n        \"name\": \"Familial Mediterranean Fever (FMF)\",\n        \"confidence\": 0.9,\n        \"icd_code\": \"E85.0\",\n        \"reasoning\": \"Recurrent episodes of fever, severe abdominal pain (peritoneal signs), and arthritis (knees and ankles) lasting 2-3 days and resolving spontaneously. Family history of similar episodes and ethnic background (Somali, high prevalence in Mediterranean populations) strongly support FMF. Elevated CRP and ESR indicate inflammation.\"\n    },\n    \"differential_diagnoses\": [\n        {\n            \"name\": \"Recurrent Acute Appendicitis\",\n            \"confidence\": 0.5,\n            \"icd_code\": \"K35.80\",\n            \"reasoning\": \"Recurrent abdominal pain with peritoneal signs and fever could mimic appendicitis. However, the migratory arthritis and spontaneous resolution are less typical, and the family history points away from it as a primary diagnosis.\"\n        },\n        {\n            \"name\": \"Systemic Lupus Erythematosus (SLE)\",\n            \"confidence\": 0.4,\n            \"icd_code\": \"M32.10\",\n            \"reasoning\": \"SLE can cause recurrent fever, polyarthritis, and serositis (abdominal pain due to peritonitis). However, the episodic nature with complete resolution between attacks and the strong family history of similar symptoms make FMF more likely. Skin rash, renal involvement, or specific autoantibodies are typically present in SLE.\"\n        },\n        {\n            \"name\": \"Inflammatory Bowel Disease (IBD) - Crohn's Disease\",\n            \"confidence\": 0.3,\n            \"icd_code\": \"K50.90\",\n            \"reasoning\": \"Crohn's disease can present with recurrent abdominal pain, fever, and arthritis (enthesitis or peripheral arthritis). However, the rapid resolution of episodes and peritoneal signs without other typical GI symptoms (diarrhea, weight loss) reduce its likelihood compared to FMF. Peritoneal signs are rare in IBD unless perforation or severe inflammation.\"\n        },\n        {\n            \"name\": \"Beh\u00e7et's Disease\",\n            \"confidence\": 0.2,\n            \"icd_code\": \"M35.2\",\n            \"reasoning\": \"Beh\u00e7et's can cause recurrent oral and genital ulcers, skin lesions, and arthritis. Abdominal pain due to vasculitis can occur. However, the prominent abdominal pain and arthritis pattern, along with the family history, make FMF a stronger fit without other classic Beh\u00e7et's features.\"\n        }\n    ],\n    \"key_findings\": [\n        \"Recurrent episodes of severe abdominal pain with peritoneal signs\",\n        \"Recurrent fever spikes (up to 39.5\u00b0C)\",\n        \"Recurrent arthritis affecting knees and ankles\",\n        \"Episodes last 2-3 days and resolve spontaneously\",\n        \"Family history of similar episodes\",\n        \"Patient is a recent immigrant from Somalia (ethnic background with higher FMF prevalence)\",\n        \"Elevated CRP and ESR during episodes\",\n        \"Pain unresponsive to standard analgesics\"\n    ],\n    \"diagnostic_tests\": [\n        {\n            \"test\": \"Genetic testing for MEFV gene mutations\",\n            \"purpose\": \"To confirm the diagnosis of Familial Mediterranean Fever (FMF). Identifies mutations in the pyrin gene.\",\n            \"priority\": \"immediate\"\n        },\n        {\n            \"test\": \"Acute phase reactants (CRP, ESR)\",\n            \"purpose\": \"To confirm active inflammation during an episode and monitor response to treatment. Already elevated, but serial monitoring is useful.\",\n            \"priority\": \"immediate\"\n        },\n        {\n            \"test\": \"Complete Blood Count (CBC) with differential\",\n            \"purpose\": \"To assess for leukocytosis during episodes and rule out other infectious causes.\",\n            \"priority\": \"immediate\"\n        },\n        {\n            \"test\": \"Abdominal Ultrasound / CT scan\",\n            \"purpose\": \"To rule out acute surgical abdominal conditions (e.g., appendicitis, cholecystitis, diverticulitis) and assess for ascites or peritonitis.\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"Serum Amyloid A (SAA)\",\n            \"purpose\": \"To assess for subclinical inflammation and risk of amyloidosis, a long-term complication of FMF.\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"Echocardiogram and Renal function tests (creatinine, urinalysis)\",\n            \"purpose\": \"To screen for amyloidosis affecting heart or kidneys, a serious complication of untreated FMF.\",\n            \"priority\": \"routine\"\n        }\n    ],\n    \"management_plan\": {\n        \"immediate_actions\": [\n            \"Pain management with strong analgesics (opioids if necessary) for acute episodes.\",\n            \"Antipyretics for fever control.\",\n            \"IV fluids for hydration if unable to tolerate oral intake due to pain/fever.\",\n            \"Rule out surgical abdomen through clinical assessment and imaging.\"\n        ],\n        \"medications\": [\n            {\n                \"drug\": \"Colchicine\",\n                \"dose\": \"0.5 mg - 1 mg BID (start low, titrate up)\",\n                \"route\": \"PO\",\n                \"duration\": \"Lifelong\",\n                \"rationale\": \"First-line prophylactic treatment for FMF to prevent attacks and reduce the risk of amyloidosis. Dosing needs careful titration based on tolerance and response.\"\n            },\n            {\n                \"drug\": \"NSAIDs (e.g., Ibuprofen)\",\n                \"dose\": \"400-600 mg TID PRN for arthralgia\",\n                \"route\": \"PO\",\n                \"duration\": \"During episodes\",\n                \"rationale\": \"For symptomatic relief of arthritis and inflammation during acute attacks, though less effective for severe abdominal pain in FMF.\"\n            },\n            {\n                \"drug\": \"Opioid Analgesics (e.g., Hydromorphone)\",\n                \"dose\": \"1-2 mg IV/IM PRN\",\n                \"route\": \"IV/IM\",\n                \"duration\": \"During acute severe attacks\",\n                \"rationale\": \"For severe abdominal pain unresponsive to standard analgesics during acute episodes, while ruling out surgical emergencies.\"\n            }\n        ],\n        \"monitoring\": [\n            \"Clinical response to colchicine (frequency and severity of attacks)\",\n            \"Adherence to colchicine therapy\",\n            \"Side effects of colchicine (diarrhea, nausea, myopathy, neutropenia)\",\n            \"Regular monitoring of CRP, ESR, and SAA levels (every 3-6 months)\",\n            \"Annual renal function tests and urinalysis for proteinuria (amyloidosis screening)\",\n            \"Annual echocardiogram if SAA persistently elevated or symptoms suggest cardiac involvement\"\n        ],\n        \"consultations\": [\n            {\n                \"specialty\": \"Rheumatology\",\n                \"urgency\": \"urgent\",\n                \"reason\": \"For confirmation of FMF diagnosis, initiation and titration of colchicine, long-term management, and monitoring for complications like amyloidosis.\"\n            },\n            {\n                \"specialty\": \"Genetics\",\n                \"urgency\": \"routine\",\n                \"reason\": \"For genetic counseling regarding MEFV gene mutations, implications for family members, and reproductive planning.\"\n            },\n            {\n                \"specialty\": \"Social Work/Interpreter Services\",\n                \"urgency\": \"immediate\",\n                \"reason\": \"To facilitate communication with the patient due to limited English proficiency and address any social determinants of health or access to care issues.\"\n            }\n        ]\n    },\n    \"red_flags\": [\n        \"Unexplained persistent abdominal pain or fever not resolving in 2-3 days\",\n        \"Signs of surgical abdomen (e.g., rebound tenderness, guarding, rigidity) that do not improve or worsen rapidly\",\n        \"Development of new symptoms (e.g., unexplained weight loss, chronic diarrhea, persistent proteinuria)\",\n        \"Signs of amyloidosis (e.g., persistent proteinuria, edema, unexplained heart failure, neuropathy)\"\n    ],\n    \"patient_education\": [\n        \"Explain Familial Mediterranean Fever (FMF) as a genetic inflammatory disorder, not an infection, and its episodic nature.\",\n        \"Emphasize the importance of lifelong daily colchicine therapy to prevent attacks and prevent long-term complications like amyloidosis.\",\n        \"Educate on potential side effects of colchicine (diarrhea, nausea) and how to manage them, and when to contact the doctor.\",\n        \"Advise on recognizing symptoms of an impending attack and when to seek medical attention (especially for severe pain or fever).\",\n        \"Discuss the genetic nature of FMF and implications for family members, offering genetic counseling.\"\n    ],\n    \"follow_up\": {\n        \"timing\": \"Within 1-2 weeks after discharge for initial rheumatology consultation, then routine follow-up with rheumatology every 3-6 months.\",\n        \"conditions\": \"Recurrence of severe symptoms, new unexplained symptoms, signs of drug intolerance, or any signs of complications like amyloidosis require immediate return.\"\n    },\n    \"confidence_in_assessment\": 0.9,\n    \"uncertainties\": [\n        \"Specific MEFV gene mutations (which would be identified by genetic testing).\",\n        \"Exact family history details beyond 'similar episodes'.\",\n        \"Presence of subclinical amyloidosis at presentation (needs SAA and other screening tests).\"\n    ]\n}\n```",
  "timestamp": "2025-08-11T19:32:52.965892",
  "latency": 13.03708291053772,
  "tokens_used": 3012,
  "input_tokens": 893,
  "output_tokens": 2119,
  "error": null,
  "raw_response": {
    "id": "gen-1754933560-r2FNZTiKCCi0rKRb90cj",
    "provider": "Google",
    "model": "google/gemini-2.5-flash",
    "object": "chat.completion",
    "created": 1754933560,
    "choices": [
      {
        "logprobs": null,
        "finish_reason": "stop",
        "native_finish_reason": "STOP",
        "index": 0,
        "message": {
          "role": "assistant",
          "content": "```json\n{\n    \"primary_diagnosis\": {\n        \"name\": \"Familial Mediterranean Fever (FMF)\",\n        \"confidence\": 0.9,\n        \"icd_code\": \"E85.0\",\n        \"reasoning\": \"Recurrent episodes of fever, severe abdominal pain (peritoneal signs), and arthritis (knees and ankles) lasting 2-3 days and resolving spontaneously. Family history of similar episodes and ethnic background (Somali, high prevalence in Mediterranean populations) strongly support FMF. Elevated CRP and ESR indicate inflammation.\"\n    },\n    \"differential_diagnoses\": [\n        {\n            \"name\": \"Recurrent Acute Appendicitis\",\n            \"confidence\": 0.5,\n            \"icd_code\": \"K35.80\",\n            \"reasoning\": \"Recurrent abdominal pain with peritoneal signs and fever could mimic appendicitis. However, the migratory arthritis and spontaneous resolution are less typical, and the family history points away from it as a primary diagnosis.\"\n        },\n        {\n            \"name\": \"Systemic Lupus Erythematosus (SLE)\",\n            \"confidence\": 0.4,\n            \"icd_code\": \"M32.10\",\n            \"reasoning\": \"SLE can cause recurrent fever, polyarthritis, and serositis (abdominal pain due to peritonitis). However, the episodic nature with complete resolution between attacks and the strong family history of similar symptoms make FMF more likely. Skin rash, renal involvement, or specific autoantibodies are typically present in SLE.\"\n        },\n        {\n            \"name\": \"Inflammatory Bowel Disease (IBD) - Crohn's Disease\",\n            \"confidence\": 0.3,\n            \"icd_code\": \"K50.90\",\n            \"reasoning\": \"Crohn's disease can present with recurrent abdominal pain, fever, and arthritis (enthesitis or peripheral arthritis). However, the rapid resolution of episodes and peritoneal signs without other typical GI symptoms (diarrhea, weight loss) reduce its likelihood compared to FMF. Peritoneal signs are rare in IBD unless perforation or severe inflammation.\"\n        },\n        {\n            \"name\": \"Beh\u00e7et's Disease\",\n            \"confidence\": 0.2,\n            \"icd_code\": \"M35.2\",\n            \"reasoning\": \"Beh\u00e7et's can cause recurrent oral and genital ulcers, skin lesions, and arthritis. Abdominal pain due to vasculitis can occur. However, the prominent abdominal pain and arthritis pattern, along with the family history, make FMF a stronger fit without other classic Beh\u00e7et's features.\"\n        }\n    ],\n    \"key_findings\": [\n        \"Recurrent episodes of severe abdominal pain with peritoneal signs\",\n        \"Recurrent fever spikes (up to 39.5\u00b0C)\",\n        \"Recurrent arthritis affecting knees and ankles\",\n        \"Episodes last 2-3 days and resolve spontaneously\",\n        \"Family history of similar episodes\",\n        \"Patient is a recent immigrant from Somalia (ethnic background with higher FMF prevalence)\",\n        \"Elevated CRP and ESR during episodes\",\n        \"Pain unresponsive to standard analgesics\"\n    ],\n    \"diagnostic_tests\": [\n        {\n            \"test\": \"Genetic testing for MEFV gene mutations\",\n            \"purpose\": \"To confirm the diagnosis of Familial Mediterranean Fever (FMF). Identifies mutations in the pyrin gene.\",\n            \"priority\": \"immediate\"\n        },\n        {\n            \"test\": \"Acute phase reactants (CRP, ESR)\",\n            \"purpose\": \"To confirm active inflammation during an episode and monitor response to treatment. Already elevated, but serial monitoring is useful.\",\n            \"priority\": \"immediate\"\n        },\n        {\n            \"test\": \"Complete Blood Count (CBC) with differential\",\n            \"purpose\": \"To assess for leukocytosis during episodes and rule out other infectious causes.\",\n            \"priority\": \"immediate\"\n        },\n        {\n            \"test\": \"Abdominal Ultrasound / CT scan\",\n            \"purpose\": \"To rule out acute surgical abdominal conditions (e.g., appendicitis, cholecystitis, diverticulitis) and assess for ascites or peritonitis.\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"Serum Amyloid A (SAA)\",\n            \"purpose\": \"To assess for subclinical inflammation and risk of amyloidosis, a long-term complication of FMF.\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"Echocardiogram and Renal function tests (creatinine, urinalysis)\",\n            \"purpose\": \"To screen for amyloidosis affecting heart or kidneys, a serious complication of untreated FMF.\",\n            \"priority\": \"routine\"\n        }\n    ],\n    \"management_plan\": {\n        \"immediate_actions\": [\n            \"Pain management with strong analgesics (opioids if necessary) for acute episodes.\",\n            \"Antipyretics for fever control.\",\n            \"IV fluids for hydration if unable to tolerate oral intake due to pain/fever.\",\n            \"Rule out surgical abdomen through clinical assessment and imaging.\"\n        ],\n        \"medications\": [\n            {\n                \"drug\": \"Colchicine\",\n                \"dose\": \"0.5 mg - 1 mg BID (start low, titrate up)\",\n                \"route\": \"PO\",\n                \"duration\": \"Lifelong\",\n                \"rationale\": \"First-line prophylactic treatment for FMF to prevent attacks and reduce the risk of amyloidosis. Dosing needs careful titration based on tolerance and response.\"\n            },\n            {\n                \"drug\": \"NSAIDs (e.g., Ibuprofen)\",\n                \"dose\": \"400-600 mg TID PRN for arthralgia\",\n                \"route\": \"PO\",\n                \"duration\": \"During episodes\",\n                \"rationale\": \"For symptomatic relief of arthritis and inflammation during acute attacks, though less effective for severe abdominal pain in FMF.\"\n            },\n            {\n                \"drug\": \"Opioid Analgesics (e.g., Hydromorphone)\",\n                \"dose\": \"1-2 mg IV/IM PRN\",\n                \"route\": \"IV/IM\",\n                \"duration\": \"During acute severe attacks\",\n                \"rationale\": \"For severe abdominal pain unresponsive to standard analgesics during acute episodes, while ruling out surgical emergencies.\"\n            }\n        ],\n        \"monitoring\": [\n            \"Clinical response to colchicine (frequency and severity of attacks)\",\n            \"Adherence to colchicine therapy\",\n            \"Side effects of colchicine (diarrhea, nausea, myopathy, neutropenia)\",\n            \"Regular monitoring of CRP, ESR, and SAA levels (every 3-6 months)\",\n            \"Annual renal function tests and urinalysis for proteinuria (amyloidosis screening)\",\n            \"Annual echocardiogram if SAA persistently elevated or symptoms suggest cardiac involvement\"\n        ],\n        \"consultations\": [\n            {\n                \"specialty\": \"Rheumatology\",\n                \"urgency\": \"urgent\",\n                \"reason\": \"For confirmation of FMF diagnosis, initiation and titration of colchicine, long-term management, and monitoring for complications like amyloidosis.\"\n            },\n            {\n                \"specialty\": \"Genetics\",\n                \"urgency\": \"routine\",\n                \"reason\": \"For genetic counseling regarding MEFV gene mutations, implications for family members, and reproductive planning.\"\n            },\n            {\n                \"specialty\": \"Social Work/Interpreter Services\",\n                \"urgency\": \"immediate\",\n                \"reason\": \"To facilitate communication with the patient due to limited English proficiency and address any social determinants of health or access to care issues.\"\n            }\n        ]\n    },\n    \"red_flags\": [\n        \"Unexplained persistent abdominal pain or fever not resolving in 2-3 days\",\n        \"Signs of surgical abdomen (e.g., rebound tenderness, guarding, rigidity) that do not improve or worsen rapidly\",\n        \"Development of new symptoms (e.g., unexplained weight loss, chronic diarrhea, persistent proteinuria)\",\n        \"Signs of amyloidosis (e.g., persistent proteinuria, edema, unexplained heart failure, neuropathy)\"\n    ],\n    \"patient_education\": [\n        \"Explain Familial Mediterranean Fever (FMF) as a genetic inflammatory disorder, not an infection, and its episodic nature.\",\n        \"Emphasize the importance of lifelong daily colchicine therapy to prevent attacks and prevent long-term complications like amyloidosis.\",\n        \"Educate on potential side effects of colchicine (diarrhea, nausea) and how to manage them, and when to contact the doctor.\",\n        \"Advise on recognizing symptoms of an impending attack and when to seek medical attention (especially for severe pain or fever).\",\n        \"Discuss the genetic nature of FMF and implications for family members, offering genetic counseling.\"\n    ],\n    \"follow_up\": {\n        \"timing\": \"Within 1-2 weeks after discharge for initial rheumatology consultation, then routine follow-up with rheumatology every 3-6 months.\",\n        \"conditions\": \"Recurrence of severe symptoms, new unexplained symptoms, signs of drug intolerance, or any signs of complications like amyloidosis require immediate return.\"\n    },\n    \"confidence_in_assessment\": 0.9,\n    \"uncertainties\": [\n        \"Specific MEFV gene mutations (which would be identified by genetic testing).\",\n        \"Exact family history details beyond 'similar episodes'.\",\n        \"Presence of subclinical amyloidosis at presentation (needs SAA and other screening tests).\"\n    ]\n}\n```",
          "refusal": null,
          "reasoning": null
        }
      }
    ],
    "usage": {
      "prompt_tokens": 893,
      "completion_tokens": 2119,
      "total_tokens": 3012
    }
  }
}